2021
DOI: 10.1016/j.jconrel.2021.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Dissolving microneedle patches loaded with amphotericin B microparticles for localised and sustained intradermal delivery: Potential for enhanced treatment of cutaneous fungal infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
37
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 65 publications
(38 citation statements)
references
References 114 publications
1
37
0
Order By: Relevance
“…MNs are microscopic projections that disrupt the top layer of the skin in a non-invasive manner, creating micron-sized channels ranging in height from 25 to 2000 µm that allow drugs to reach the epidermis or upper dermis directly [283,286,289]. MNs have facilitated the transdermal delivery of not only low-molecular weight drugs [290,291] but also hydrophilic molecules [292,293], peptides and proteins [294][295][296][297], cosmeceuticals [298][299][300], microparticles [301,302], NEs [303], vaccines [304], and nanoparticles [285,305].…”
Section: Mechanical Approachesmentioning
confidence: 99%
See 2 more Smart Citations
“…MNs are microscopic projections that disrupt the top layer of the skin in a non-invasive manner, creating micron-sized channels ranging in height from 25 to 2000 µm that allow drugs to reach the epidermis or upper dermis directly [283,286,289]. MNs have facilitated the transdermal delivery of not only low-molecular weight drugs [290,291] but also hydrophilic molecules [292,293], peptides and proteins [294][295][296][297], cosmeceuticals [298][299][300], microparticles [301,302], NEs [303], vaccines [304], and nanoparticles [285,305].…”
Section: Mechanical Approachesmentioning
confidence: 99%
“…Microparticles and nanoparticles are being used in a new generation of MNs to help achieve long-acting benefit after delivery into the body [309]. To provide targeted and long-acting intradermal distribution of amphotericin B for the treatment of cutaneous fungal infections, dissolving MNs loaded with micronized particles of amphotericin B were developed by the Donnelly research group [301]. Amphotericin B concentrations in plasma, kidneys, liver, and spleen were significantly lower in the MN group than in the intravenous group, according to pharmacokinetic and biodistribution studies.…”
Section: Integrating Chemical and Physical Technologiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Current microneedle studies have mainly focused on the delivery of insulin [ 8 , 13 , 14 ] and vaccines [ 15 , 16 ], antibodies for cancer immunotherapy [ 17 ], and high molecular weight drugs [ 18 ]. A few microneedle studies have been published that aim to control bacterial and fungal biofilms, and have mainly focused on delivering antibiotics [ 19 ], antifungal agents [ 20 ], carvacrol [ 21 ], silver nanoparticles [ 22 ], elevating oxygenation [ 23 ].…”
Section: Introductionmentioning
confidence: 99%
“…explored and demonstrated the utility of using dissolving microneedles to achieve localised and long-acting intradermal delivery of Amphotericin B, an antifungal agent, for the treatment of cutaneous fungal infections. In the work, the researchers demonstrated that the microneedles were able to be inserted into the skin to a depth of 300 µm resulting localised release of Amphotericin B into the dermis, the location where most fungal infections typically reside ( 18 ). Furthering this, Sabri et al .…”
Section: Introductionmentioning
confidence: 99%